141 related articles for article (PubMed ID: 15965979)
1. BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension.
Sankelo M; Flanagan JA; Machado R; Harrison R; Rudarakanchana N; Morrell N; Dixon M; Halme M; Puolijoki H; Kere J; Elomaa O; Kupari M; Räisänen-Sokolowski A; Trembath RC; Laitinen T
Hum Mutat; 2005 Aug; 26(2):119-24. PubMed ID: 15965979
[TBL] [Abstract][Full Text] [Related]
2. A novel mutation in the BMPR2 gene in familial pulmonary arterial hypertension.
Fu LJ; Zhou AQ; Huang MR; Shen SH; Shen J; Zhang ZF; Li F
Chin Med J (Engl); 2008 Mar; 121(5):399-404. PubMed ID: 18364108
[TBL] [Abstract][Full Text] [Related]
3. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel mutation in the gene for bone morphogenetic protein receptor II in an Israeli patient with familial primary pulmonary hypertension.
Cahn A; Meiner V; Leitersdorf E; Berkman N
Isr Med Assoc J; 2004 Mar; 6(3):156-9. PubMed ID: 15055271
[TBL] [Abstract][Full Text] [Related]
5. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family.
Thomson JR; Machado RD; Pauciulo MW; Morgan NV; Humbert M; Elliott GC; Ward K; Yacoub M; Mikhail G; Rogers P; Newman J; Wheeler L; Higenbottam T; Gibbs JS; Egan J; Crozier A; Peacock A; Allcock R; Corris P; Loyd JE; Trembath RC; Nichols WC
J Med Genet; 2000 Oct; 37(10):741-5. PubMed ID: 11015450
[TBL] [Abstract][Full Text] [Related]
6. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
Li W; Hu H
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
[TBL] [Abstract][Full Text] [Related]
7. Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred.
Newman JH; Wheeler L; Lane KB; Loyd E; Gaddipati R; Phillips JA; Loyd JE
N Engl J Med; 2001 Aug; 345(5):319-24. PubMed ID: 11484688
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and genetic characteristics of a Chinese family of primary pulmonary hypertension].
Jing ZC; Lu LH; Zou YB; You SJ; Han ZY; Zhang Q; Yang YJ; Hui RT; Cheng XS
Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(3):199-202. PubMed ID: 15059534
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the BMPR2 5'-untranslated region and a novel mutation in pulmonary hypertension.
Aldred MA; Machado RD; James V; Morrell NW; Trembath RC
Am J Respir Crit Care Med; 2007 Oct; 176(8):819-24. PubMed ID: 17641158
[TBL] [Abstract][Full Text] [Related]
10. BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension.
Aldred MA; Vijayakrishnan J; James V; Soubrier F; Gomez-Sanchez MA; Martensson G; Galie N; Manes A; Corris P; Simonneau G; Humbert M; Morrell NW; Trembath RC
Hum Mutat; 2006 Feb; 27(2):212-3. PubMed ID: 16429403
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension.
Rosenzweig EB; Morse JH; Knowles JA; Chada KK; Khan AM; Roberts KE; McElroy JJ; Juskiw NK; Mallory NC; Rich S; Diamond B; Barst RJ
J Heart Lung Transplant; 2008 Jun; 27(6):668-74. PubMed ID: 18503968
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L
N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 TAT represses transcription of the bone morphogenic protein receptor-2 in U937 monocytic cells.
Caldwell RL; Gadipatti R; Lane KB; Shepherd VL
J Leukoc Biol; 2006 Jan; 79(1):192-201. PubMed ID: 16282533
[TBL] [Abstract][Full Text] [Related]
14. Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension.
Machado RD; James V; Southwood M; Harrison RE; Atkinson C; Stewart S; Morrell NW; Trembath RC; Aldred MA
Circulation; 2005 Feb; 111(5):607-13. PubMed ID: 15699281
[TBL] [Abstract][Full Text] [Related]
15. [Study of the BMPR2 gene in patients with pulmonary arterial hypertension].
Portillo K; Santos S; Madrigal I; Blanco I; Paré C; Borderías L; Peinado VI; Roca J; Milà M; Barberà JA
Arch Bronconeumol; 2010 Mar; 46(3):129-34. PubMed ID: 20096498
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers.
Chida A; Shintani M; Yagi H; Fujiwara M; Kojima Y; Sato H; Imamura S; Yokozawa M; Onodera N; Horigome H; Kobayashi T; Hatai Y; Nakayama T; Fukushima H; Nishiyama M; Doi S; Ono Y; Yasukouchi S; Ichida F; Fujimoto K; Ohtsuki S; Teshima H; Kawano T; Nomura Y; Gu H; Ishiwata T; Furutani Y; Inai K; Saji T; Matsuoka R; Nonoyama S; Nakanishi T
Am J Cardiol; 2012 Aug; 110(4):586-93. PubMed ID: 22632830
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
Sztrymf B; Coulet F; Girerd B; Yaici A; Jais X; Sitbon O; Montani D; Souza R; Simonneau G; Soubrier F; Humbert M
Am J Respir Crit Care Med; 2008 Jun; 177(12):1377-83. PubMed ID: 18356561
[TBL] [Abstract][Full Text] [Related]
18. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
[TBL] [Abstract][Full Text] [Related]
19. Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension.
Elliott CG; Glissmeyer EW; Havlena GT; Carlquist J; McKinney JT; Rich S; McGoon MD; Scholand MB; Kim M; Jensen RL; Schmidt JW; Ward K
Circulation; 2006 May; 113(21):2509-15. PubMed ID: 16717148
[TBL] [Abstract][Full Text] [Related]
20. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
